Check out the study “Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis”

Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis
Share

Have you already read this interesting publication on ERJ Open Research? 📑 📢

Check out the study “Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis” to delve into the key findings and implications.

We congratulate the team for their hard work and dedication! Read the publication here: https://openres.ersjournals.com/content/8/4/00240-2022